SHW
- Product code
- SHW
- Device name
- Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis
- Device class
- Class 2
- 21 CFR
- 21 CFR 864.3755
- Medical specialty
- Pathology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
FDA classification definition
A pathology software algorithm device analyzing digital images for cancer prognosis is a software intended to analyze scanned whole slide images (WSIs) from breast cancer specimens prepared from formalin fixed paraffin-embedded (FFPE) tissue and stained using Hematoxylin & Eosin (H&E) stains. The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name |
|---|---|---|---|
| K254115 | 2026-05-04 | Artera, Inc. | ArteraAI Breast |
Official FDA classification page: SHW
Classification and pathway per current FDA publications. Data from openFDA (CC0).